X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with IPCA Labs - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs IPCA LABS - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. IPCA LABS WOCKHARDT LTD./
IPCA LABS
 
P/E (TTM) x -18.2 38.8 - View Chart
P/BV x 3.0 3.0 100.3% View Chart
Dividend Yield % 1.1 0.2 640.0%  

Financials

 WOCKHARDT LTD.   IPCA LABS
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-17
IPCA LABS
Mar-17
WOCKHARDT LTD./
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs1,129643 175.6%   
Low Rs627503 124.7%   
Sales per share (Unadj.) Rs363.1254.4 142.7%  
Earnings per share (Unadj.) Rs-20.416.1 -127.2%  
Cash flow per share (Unadj.) Rs-7.029.8 -23.4%  
Dividends per share (Unadj.) Rs10.001.00 1,000.0%  
Dividend yield (eoy) %1.10.2 652.5%  
Book value per share (Unadj.) Rs301.8194.6 155.1%  
Shares outstanding (eoy) m110.55126.20 87.6%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x2.42.3 107.4%   
Avg P/E ratio x-42.935.7 -120.4%  
P/CF ratio (eoy) x-125.919.2 -654.2%  
Price / Book Value ratio x2.92.9 98.8%  
Dividend payout %-48.96.2 -785.9%   
Avg Mkt Cap Rs m97,06372,300 134.3%   
No. of employees `0006.813.3 50.9%   
Total wages/salary Rs m9,6656,960 138.9%   
Avg. sales/employee Rs Th5,931.82,413.5 245.8%   
Avg. wages/employee Rs Th1,428.1523.2 273.0%   
Avg. net profit/employee Rs Th-334.0152.4 -219.1%   
INCOME DATA
Net Sales Rs m40,14632,106 125.0%  
Other income Rs m1,143226 506.2%   
Total revenues Rs m41,28932,332 127.7%   
Gross profit Rs m1284,448 2.9%  
Depreciation Rs m1,4891,730 86.1%   
Interest Rs m2,253241 935.5%   
Profit before tax Rs m-2,4722,703 -91.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-211675 -31.3%   
Profit after tax Rs m-2,2602,028 -111.5%  
Gross profit margin %0.313.9 2.3%  
Effective tax rate %8.525.0 34.2%   
Net profit margin %-5.66.3 -89.1%  
BALANCE SHEET DATA
Current assets Rs m46,16017,340 266.2%   
Current liabilities Rs m19,2589,559 201.5%   
Net working cap to sales %67.024.2 276.5%  
Current ratio x2.41.8 132.1%  
Inventory Days Days101100 100.4%  
Debtors Days Days9457 165.4%  
Net fixed assets Rs m40,16520,779 193.3%   
Share capital Rs m553252 219.0%   
"Free" reserves Rs m32,81424,499 133.9%   
Net worth Rs m33,36724,553 135.9%   
Long term debt Rs m31,9033,517 907.0%   
Total assets Rs m89,68739,595 226.5%  
Interest coverage x-0.112.2 -0.8%   
Debt to equity ratio x1.00.1 667.4%  
Sales to assets ratio x0.40.8 55.2%   
Return on assets %05.7 -0.1%  
Return on equity %-6.88.3 -82.0%  
Return on capital %-0.310.5 -3.2%  
Exports to sales %048.6 0.0%   
Imports to sales %014.2 0.0%   
Exports (fob) Rs mNA15,617 0.0%   
Imports (cif) Rs mNA4,571 0.0%   
Fx inflow Rs m9,12115,617 58.4%   
Fx outflow Rs m2,1335,828 36.6%   
Net fx Rs m6,9889,790 71.4%   
CASH FLOW
From Operations Rs m-2,6952,764 -97.5%  
From Investments Rs m-6,863-1,432 479.3%  
From Financial Activity Rs m12,545-1,591 -788.3%  
Net Cashflow Rs m3,010-259 -1,163.2%  

Share Holding

Indian Promoters % 74.5 45.9 162.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 11.4 20.2%  
FIIs % 7.7 25.3 30.4%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 17.4 88.5%  
Shareholders   67,757 36,892 183.7%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   ALEMBIC PHARMA  STRIDES SHASUN LTD  TTK HEALTHCARE  JUBILANT LIFE SCIENCES  DISHMAN PHARMA  

Compare WOCKHARDT LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Jan 19, 2018 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. - TORRENT PHARMA COMPARISON

COMPARE WOCKHARDT LTD. WITH

MARKET STATS